DU Zhi, Zhao Xing-li, Gao Ying-tang, Wu Chen-xuan, Wang Yi-jun, Zhu Zheng-yan, Sun Quan, Fang Shu-chang
Artificial Cells Key Lab of Tianjin, Tianjin Third Central Hospital, Tianjin 300170, China.
Zhonghua Zhong Liu Za Zhi. 2008 Oct;30(10):759-63.
To investigate the practical possibility of inducing dendritic cells (DCs) from mononuclear cells in the lost blood during operation of hepatocellular carcinoma (HCC) patients, and attempted to find a new source of precursor cells for the personalized immunotherapy based on DCs.
Collected lost blood during hepatectomy from 9 HCC patients and human cord blood from 8 cases of healthy donors undergoing caesarean section. Their mononuclear cells were divided into monocytes and nonadherent lymphocytes. RhGM-CSF and rhIL-4 were administered to induce the monocytes differentiation into DCs, and then loaded with different antigens (lysate antigen of autologous liver cancer cells and cell line SMMC-7721 cells). The lymphocytes were induced into cytokine-induced killer cells (CIK) with IL-2, CD3-Ab, gamma-IFN and PHA. MTT assay was performed to detect the proliferation rate of T lymphocytes mediated by DC and the cytotoxicity of CIK to liver cancer cells.
DCs induced from monocytes of the intra-operative lost blood possessed typical morphology and phenotypes. Compared with the DCs from cord blood, the DCs from intra-operative lost blood expressed lower level of surface markers, but both could effectively induce proliferation of CIK and enhance the cytotoxicity of activated CIK against liver cancer cells at similar levels. When the DCs from lost blood and their counterpart from cord blood were both loaded with autologous tumor cell antigen, the proliferation rates of CIK were (388.9 +/- 137.3)% and (315.1 +/- 44.5)%, respectively, and the killing rates against tumor cells were (87.1 +/- 8.0)% and (90.0 +/- 5.1)%, respectively. When the two similar DC groups were loaded with lysate antigen of SMMC-7721 cells, the proliferation rates of CIK were (239.9 +/- 48.7)% and (226.3 +/- 32.3)%, respectively, and the killing rates against tumor cells were (76.4 +/- 7.9)% and (81.1 +/- 4.3)%, respectively. There were no significant differences between those two DC groups. The data also showed that the proliferation and cytotoxicity of CIK induced by DCs loaded with autologous antigen were higher than that of DCs loaded with SMMC-7721 antigen.
Mononuclear cells separated from intra-operative lost blood of HCC patients can be induced into mature DCs, which can effectively activate CIK and significantly increase its killing effect on the liver cancer cells, and may become a new source of DCs to study and develop vaccines for clinical application.
探讨从肝细胞癌(HCC)患者手术中失血的单核细胞诱导生成树突状细胞(DCs)的实际可能性,并试图寻找基于DCs的个性化免疫治疗的新前体细胞来源。
收集9例HCC患者肝切除术中的失血以及8例健康剖宫产产妇的脐带血。将其单核细胞分为单核细胞和非贴壁淋巴细胞。给予重组人粒细胞巨噬细胞集落刺激因子(rhGM-CSF)和重组人白细胞介素-4(rhIL-4)诱导单核细胞分化为DCs,然后负载不同抗原(自体肝癌细胞和细胞系SMMC-7721细胞的裂解物抗原)。用白细胞介素-2、抗CD3抗体、γ-干扰素和植物血凝素将淋巴细胞诱导为细胞因子诱导的杀伤细胞(CIK)。采用MTT法检测DC介导的T淋巴细胞增殖率以及CIK对肝癌细胞的细胞毒性。
术中失血单核细胞诱导生成的DCs具有典型的形态和表型。与脐带血来源的DCs相比,术中失血来源的DCs表面标志物表达水平较低,但两者均可有效诱导CIK增殖,并在相似水平上增强活化CIK对肝癌细胞的细胞毒性。当失血来源的DCs和脐带血来源的DCs均负载自体肿瘤细胞抗原时,CIK的增殖率分别为(388.9±137.3)%和(315.1±44.5)%,对肿瘤细胞的杀伤率分别为(87.1±8.0)%和(90.0±5.1)%。当两组相似的DC负载SMMC-7721细胞裂解物抗原时,CIK的增殖率分别为(239.9±48.7)%和(226.3±32.3)%,对肿瘤细胞的杀伤率分别为(76.4±7.9)%和(81.1±4.3)%。两组DC之间无显著差异。数据还显示,负载自体抗原的DC诱导的CIK的增殖和细胞毒性高于负载SMMC-7721抗原的DC。
HCC患者术中失血分离出的单核细胞可诱导生成成熟DCs,其能有效激活CIK并显著增强其对肝癌细胞的杀伤作用,可能成为研究和开发临床应用疫苗的DC新来源。